Cargando…

Biomarker Qualification at the European Medicines Agency: A Look Under the Hood

Detalles Bibliográficos
Autores principales:	Berman, Steven, Siegel, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322337/ https://www.ncbi.nlm.nih.gov/pubmed/35500535 http://dx.doi.org/10.1002/cpt.2609

Ejemplares similares

Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
por: Bakker, Elisabeth, et al.
Publicado: (2022)

European Medicines Agency Conflicts With the European Food Safety Authority (EFSA) on Bisphenol A Regulation
por: Zoeller, R Thomas, et al.
Publicado: (2023)

Perspectives on statistical strategies for the regulatory biomarker qualification process
por: Hendrix, Suzanne B, et al.
Publicado: (2021)

The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021)

Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
por: Schuessler‐Lenz, Martina, et al.
Publicado: (2019)

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective
por: Manolis, Efthymios, et al.
Publicado: (2023)

Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson’s Patients Using Digital Mobility Outcomes
por: Viceconti, Marco, et al.
Publicado: (2020)

Windows XP under the hood
por: Knittel, Brian
Publicado: (2003)

Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers
por: Malottki, Kinga, et al.
Publicado: (2014)

Biomarker and Companion Diagnostics—A Review of Medicinal Products Approved by the European Medicines Agency
por: Orellana García, Laura Patricia, et al.
Publicado: (2021)

Under the hood of a moving cell
por: Romet-Lemonne, Guillaume
Publicado: (2022)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
por: Malottki, Kinga, et al.
Publicado: (2011)

“Getting Under the Hood” of Neuronal Signaling in Caenorhabditis elegans
por: Williams, Paul DE, et al.
Publicado: (2018)

A look under the hood of genomic-estimated breed compositions for brangus cattle: What have we learned?
por: Li, Zhi, et al.
Publicado: (2023)

Version 2.0 - Under the hood
por: Mönnich, Adrian
Publicado: (2017)

The hoods /
por: Grey, Harry

A bacteriophage journey at the European Medicines Agency
por: Debarbieux, Laurent, et al.
Publicado: (2015)

Report from the EMA workshop on qualification and reporting of physiologically based pharmacokinetic (PBPK) modeling and simulation
por: Zhao, P
Publicado: (2017)

Cellular therapies in trauma and critical care medicine: Looking towards the future
por: Pati, Shibani, et al.
Publicado: (2017)

Psychopharmacology at the era of EMEA (European Medicines Agency)
por: Pestana, Luis Camara, et al.
Publicado: (2010)

Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
por: Hendrikse, Natalie M., et al.
Publicado: (2022)

EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines
por: Steeg, Rachel, et al.
Publicado: (2021)

Industry perspectives on biomarker qualification
por: Lavezzari, G, et al.
Publicado: (2015)

Robin Hood
Publicado: (1984)

Chromosomes in the ‘hood
por: Wells, William A.
Publicado: (2003)

The Case of Deborah Rice: Who Is the Environmental Protection Agency Protecting?
por: Needleman, Herbert L
Publicado: (2008)

The European Medicines Agency's approval of new medicines for type 2 diabetes
por: Blind, Eberhard, et al.
Publicado: (2018)

Under the Hood: Skeletal Muscle Determinants of Endurance Performance
por: van der Zwaard, Stephan, et al.
Publicado: (2021)

Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei
por: Villarejo-Campos, Pedro, et al.
Publicado: (2023)

The future of training in intensive care medicine: A European perspective
por: Makris, Demosthenes, et al.
Publicado: (2022)

European Sexual Medicine Network: a unique platform for collaboration
por: Greil-Soyka, Marianne, et al.
Publicado: (2020)

One Agency's Contribution to Creating a Culture of Health in a Latinx Community
por: Fernandez, Mariela, et al.
Publicado: (2019)

Bioart and Bildung—Wetware: Art, Agency, Animation, an Exhibition as Case Study
por: Terranova, Charissa N.
Publicado: (2016)

The need for adolescents’ agency in salutogenic approaches shaping physical activity in schools
por: Boonekamp, Gwendolijn M M, et al.
Publicado: (2021)

Candidates for the Triple Qualification in Medicine and Surgery
Publicado: (1888)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019)

Reviewing the evidence supporting predictive biomarkers in European medicines agency indications and contraindications using visual plots
por: Malottki, Kinga, et al.
Publicado: (2015)

Thomas W. Hood
Publicado: (1889)

Hood’s Illustration of Hydropathy
Publicado: (1849)

Cannot write session to /tmp/vufind_sessions/sess_u6i5mieq7noph8eousur9djerl